Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed software/document revision identifier was updated from v3.5.2 to v3.5.3 without changing the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T22:20:31.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:15:30.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Study Protocol and Statistical Analysis Plan document version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T23:21:29.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No user-facing content appears to be changed.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:24.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown. The previously displayed notices about government funding lapse (v3.4.1) have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T04:43:06.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page now shows an administrative notice about a lapse in government funding and an updated revision tag (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T03:28:40.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.